| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c84ad02e3ecbbb893d9d1446ffaa0eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_35c1826c7f123391e3836c857ab0e489
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b383d0bfeee548e5df2f03de2c26b2e1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 |
| filingDate |
2006-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_482888503947591396952639bdc1c9a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53779aac7f2a9f30f648cd3fa7751947
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_328de84ac9a6f4579c21dba673aaf0d0 |
| publicationDate |
2007-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007054885-A1 |
| titleOfInvention |
Use of zolendronate for the manufacture of a medicament for the treatment of bone metabolism diseases |
| abstract |
A method of intravenously administering a bisphosphonate to a patient in need of bisphosphonate treatment comprising intravenously administering 4 mg of 2-(imidazol-lyl)-1-hydroxyethane-1,1-diphosphonic acid (zoledronic acid) or a pharmaceutically acceptable salt thereof over a period of 15 minutes to a patient in need of said treatment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102000035-A |
| priorityDate |
2000-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |